A bedaquiline/clofazimine combination regimen might add activity to the treatment of clinically relevant non-tuberculous mycobacteria-Reference-Cited by-同舟云学术

A bedaquiline/clofazimine combination regimen might add activity to the treatment of clinically relevant non-tuberculous mycobacteria

Published:2019-01-10 Issue:4 Volume:74 Page:935-943
ISSN:0305-7453
Container-title:Journal of Antimicrobial Chemotherapy
language:en
Short-container-title:

Author:

Ruth Mike Marvin¹^ORCID,Sangen Jasper J N¹,Remmers Karlijn¹,Pennings Lian J¹,Svensson Elin²³,Aarnoutse Rob E²,Zweijpfenning Sanne M H⁴,Hoefsloot Wouter⁴,Kuipers Saskia¹,Magis-Escurra Cecile⁴,Wertheim Heiman F L¹,van Ingen Jakko¹

Affiliation:

1. Department of Medical Microbiology, Radboud University Medical Center, Nijmegen, The Netherlands

2. Department of Pharmacy, Radboud University Medical Center, Nijmegen, The Netherlands

3. Department of Pharmaceutical Biosciences, Uppsala University, Uppsala, Sweden

4. Department of Pulmonary Diseases, Radboud University Medical Center, Nijmegen, The Netherlands

Funder

Netherlands Organization for Scientific research NWO

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology,Microbiology (medical)

Link

http://academic.oup.com/jac/article-pdf/74/4/935/28078181/dky526.pdf

Reference30 articles.

1. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases;Griffith;Am J Respir Crit Care Med,2007

2. The geographic diversity of nontuberculous mycobacteria isolated from pulmonary samples: an NTM-NET collaborative study;Hoefsloot;Eur Respir J,2013

3. Update on pulmonary disease due to non-tuberculous mycobacteria;Stout;Int J Infect Dis,2016

4. US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis: executive summary;Floto;Thorax,2016

5. Drug treatment of pulmonary nontuberculous mycobacterial disease in HIV-negative patients: the evidence;van Ingen;Expert Rev Anti Infect Ther,2013

Cited by 78 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Applications and advances in molecular diagnostics: revolutionizing non-tuberculous mycobacteria species and subspecies identification;Frontiers in Public Health;2024-06-19

2. Tackling Nontuberculous Mycobacteria by Repurposable Drugs and Potential Leads from Natural Products;Current Topics in Medicinal Chemistry;2024-06

3. Variation in drug penetration does not account for the natural resistance ofMycobacterium abscessusbiofilms to antibiotic;2024-04-16

4. Therapy of Mycobacterium abscessus Infections in Solid Organ Transplant Patients;Microorganisms;2024-03-16

5. Sudapyridine (WX-081) antibacterial activity against Mycobacterium avium , Mycobacterium abscessus , and Mycobacterium chelonae in vitro and in vivo;mSphere;2024-02-28